April 14, 2020
BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical long-term study
Media
April 14, 2020
GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa
April 09, 2020
The board of directors of Orexo withdraws proposal on incentive program
April 08, 2020
Nordic Nanovector Announces New Date for Annual General Meeting
April 06, 2020
GenSight Biologics Provides Update on Operations in the Context of COVID-19
April 06, 2020
Aprea Therapeutics Launches New Corporate Website – www.aprea.com
April 03, 2020
BONESUPPORT HOLDING AB (publ) publishes 2019 Annual Report and comments on effects of COVID-19
April 02, 2020
Oncopeptides strengthens its corporate communications function by appointing Rolf Gulliksen as Global Head of Corporate Communications
April 01, 2020
Nordic Nanovector Announces Focus on Advancing PARADIGME and Actions to Extend Cash Runway into 2021
March 31, 2020
Vicore Pharma submits Letter of Intent for a clinical trial application for a phase II study in patients with COVID-19, SARS CoV-2 infection
